POMDOCTOR Approves ADR Termination, Nasdaq Direct Listing, and 10-for-1 Share Consolidation

Filing content

Shareholders approved the termination of the ADR program, a direct listing on Nasdaq, and a 10-for-1 share consolidation, which will take effect simultaneously with the ADR termination and listing.